![]() Celgene Celgene is a biopharmaceutical company developing therapies for the treatment of cancer and inflammatory diseases. | ![]() Sanofi Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. | ![]() Idorsia Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. | ![]() Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. | ![]() Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines. | ![]() Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. | |
Founding Date | Founding Date 1986 | Founding Date 2004 | Founding Date 2017 | Founding Date 1980 | Founding Date 1987 | Founding Date 1988 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||
Locations | Locations Summit, US HQ Singapore, SG Boudry, CH | Locations Allschwil, CH HQ Shanghai, CN Lörrach, DE Chiyoda City, JP | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more | Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more | |
Employees | Employees 8,85219% increase | Employees 86,088 | Employees 8007% increase | Employees 25,200 | Employees 18,0006% increase | Employees 13,9264% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 141.1 b | Valuation ($) N/A | Valuation ($) 170.4 b | Valuation ($) 110.5 b | Valuation ($) 102.2 b |
Financial | ||||||
Revenue (est.) | Revenue (est.) $15.3b (FY, 2018) | Revenue (est.) €43.1b (FY, 2023) | Revenue (est.) CHF152.4m (FY, 2023) | Revenue (est.) $28.2b (FY, 2023) | Revenue (est.) $27.1b (FY, 2023) | Revenue (est.) $13.1b (FY, 2023) |
Cost of goods | Cost of goods $587m (FY, 2018) | Cost of goods €12.5b (FY, 2023) | Cost of goods CHF7.2m (FY, 2023) | Cost of goods $8.5b (FY, 2023) | Cost of goods $6.5b (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $14.7b (FY, 2018) | Gross profit €34.5b (FY, 2023) | Gross profit CHF146.4m (FY, 2023) | Gross profit $19.7b (FY, 2023) | Gross profit $20.6b (FY, 2023) | Gross profit N/A |
Net income | Net income $4b (FY, 2018) | Net income €5.6b (FY, 2023) | Net income (CHF297.9m) (FY, 2023) | Net income $6.7b (FY, 2023) | Net income $5.6b (FY, 2023) | Net income $4b (FY, 2023) |
Operating ⚠ | ||||||
Countries | Countries N/A | Countries N/A | Countries N/A | Countries 100 (FY, 2020) | Countries 35 (FY, 2021) | Countries N/A |
Patents (EU) | Patents (EU) N/A | Patents (EU) N/A | Patents (EU) N/A | Patents (EU) 21 (FY, 2020) | Patents (EU) N/A | Patents (EU) 17 (FY, 2020) |
Patents (US) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A | Patents (US) 31 (FY, 2020) | Patents (US) N/A | Patents (US) 31 (FY, 2020) |
Phase I Trials Products (Oncology) | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) 9 (FY, 2021) | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) 7 (FY, 2019) | Phase I Trials Products (Oncology) N/A |
Phase II Trials Products (Oncology) | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) 12 (FY, 2021) | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) 1 (FY, 2021) | Phase II Trials Products (Oncology) N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 11 (FY, 2020) | Phase III Trials Products 9 (FY, 2021) | Phase III Trials Products N/A |
Products | Products N/A | Products N/A | Products N/A | Products N/A | Products 21 (FY, 2021) | Products 11 (FY, 2022) |
Projects in R&D Pipeline | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 91 (FY, 2019) | Projects in R&D Pipeline 12 (FY, 2019) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A |
Funding | ||||||
Total funding raised | Total funding raised N/A | Total funding raised $ 310m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 53.9m |
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
View companyIdorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
View companyAmgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View companyGilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
View company